Haier Biomedical
Tracked across 5 events · 41 articles · First seen Apr 10, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Haier Biomedical showcased its full-scenario laboratory solutions at analytica 2026, highlighting its deepening localization strategy and product innovations, which is expected to strengthen its market position in Europe.
Apr 10, 2026 · 7 articles
Tech
Impact: Haier Biomedical launched new automated low-carbon cold storage products at two major global trade fairs, strengthening its global market presence and demonstrating its commitment to localized innovation and service.
Jun 25, 2026 · 6 articles
Tech
Impact: Haier Biomedical is the maker of the Sweden — Stockholm test and is actively pursuing FDA approval for its use in routine screening in the United States. The positive study results are crucial for its commercialization efforts.
Jun 26, 2026 · 6 articles
Business
Impact: Haier Biomedical continues to deliver key overseas projects, such as the UK Biobank, and holds the No. 1 market share in seven countries.
May 18, 2026 · 13 articles
90
Haier Biomedical launched productsHaier Biomedical Debuts...
80
Haier Biomedical strengthened presenceHaier Biomedical Debuts...
80
Haier Biomedical developed testStockholm3 Blood Test...
70
Haier Biomedical plans to seek approval United States — Food and Drug AdministrationStockholm3 Blood Test...
ERGEN INTELLIGENCE
Track Haier Biomedical live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard